Log in to save to my catalogue

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angi...

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A574208018

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop

About this item

Full title

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop

Publisher

Nature Publishing Group

Journal title

Oncogene, 2019-02, Vol.38 (7), p.1050

Language

English

Formats

Publication information

Publisher

Nature Publishing Group

More information

Scope and Contents

Contents

Vascular endothelial growth factor-A (VEGF-A) is highly subjected to alternative pre-mRNA splicing that generates several splice variants. The VEGF.sub.xxx and VEGF.sub.xxxb families encode splice variants of VEGF-A that differ only at the level of six amino acids in their C-terminal part. The expression level of VEGF.sub.xxx splice variants and th...

Alternative Titles

Full title

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A574208018

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A574208018

Other Identifiers

ISSN

0950-9232

DOI

10.1038/s41388-018-0486-7

How to access this item